Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Xynomic Research Institute Has Successfully Designed a Series of Potent RET Kinase Inhibitors
Saturday, August 17, 2019Xynomic Pharmaceuticals Holdings Inc a clinical stage USChina oncology drug development company announced that Xynomic Research Institute XRI has successfully designed a series of potent RET kinase inhibitors by computerassisted drug design
GeneCentric Therapeutics Acquires Select ImmunoGenomics
Friday, August 16, 2019GeneCentric Therapeutics Inc today announced that it has acquired Select ImmunoGenomics LLC a Chapel Hill NCbased provider of advanced immunogenomic data analysis and biomarker development services to support the development of immunooncology drugs
Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets
Friday, August 16, 2019Phio Pharmaceuticals Corp a biotechnology company developing the next generation of immunooncology therapeutics based on its proprietary selfdelivering RNAi sdrxRNA therapeutic platform announced today that is has entered into a research collaboratio...
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Wednesday, August 14, 2019AskBio the worlds foremost clinical stage and gene therapy platform company has acquired Synpromics the leader in gene control synthetic promoter technology bioinformatics and intelligent datadriven design that enables more precise cell targeting and...
CureVac Enters into an Exclusive Collaborative Research Agreement for Discovery Research in mRNA-based Lung Therapy Candidates with Yale University
Wednesday, August 14, 2019CureVac AG a fully integrated biopharmaceutical company pioneering the field of mRNAbased drugs announced today it has entered into a Collaborative Research Agreement CRA with Yale University for discovery research into mRNAbased pulmonary therapeuti...
Onconova Therapeutics and Mission Bio Partner to Advance Precision Oncology Clinical Trials Employing Single-Cell Genomics
Tuesday, August 13, 2019Onconova Therapeutics Inc a Phase stage biopharmaceutical company discovering and developing novel products to treat cancer with a focus on Myelodysplastic Syndromes MDS and Mission Bio the pioneer in targeted singlecell DNA analysis and precision g...
Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA® (Pembrolizumab)
Tuesday, August 13, 2019Oncologie Inc a clinicalstage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment today announced that it has entered into a clinical collaboration agreement with Merck known as MSD outside the US...
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Friday, August 09, 2019Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics a privately held USheadquartered biotechnology company focused on developing engineered cell therapies in the fields of neurolo...
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent® For Therapeutic Platform
Thursday, August 08, 2019Vesselon an oncology therapeutics company today announced the acquisition of an FDAapproved drug Imagent Vesselon will use Imagent to create novel therapeutic complexes in four classes of cancer drugs cytokines oncolytic viruses monoclonal antibodies...
Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14
Thursday, August 08, 2019Caladrius Biosciences Inc a latestage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular and autoimmune diseases and Cognate BioServices Inc Cognate a leading contract development and...
